The emerging challenge is no longer whether we can produce profound metabolic benefits, but rather how to optimise durability, individualise receptor targeting and translate these complex pharmacologic innovations into long term clinical decision making
10.1016/j.cmet.2013.07.002 64 KeelerA
Mounjaro is approved for type 2 diabetes management, while Zepbound is approved for chronic weight management in adults with obesity or in those overweight with a weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes
Radak, Z., Zhao, Z., Goto, S., & Koltai, E
A Skin-Longevity Approach to Volume, Hydration, Firmness, and Recovery Significant weight loss can change more than the number on the scale